Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Fc gamma RI/CD64 Antibody (H22), PE, Novus Biologicals™
SDP

Human Monoclonal Antibody

Supplier:  Novus Biologicals NBP281097PE

Catalog No. NB016007


Only null left
Add to Cart

Description

Description

Fc gamma RI/CD64 Monoclonal specifically detects Fc gamma RI/CD64 in Human samples. It is validated for Flow Cytometry.
Specifications

Specifications

Fc gamma RI/CD64
Monoclonal
PE
PBS
FCGR1A
This recombinant antibody was prepared by cloning the single chain fragment (scFv) derived from the murine anti-human Fc gamma RI/CD64 mAb m22 into the bacterial expression vector pBM1.1, and fusing it to a deletion mutant of Pseudomonas exotoxin A.
0.1 mL
Primary
This immunotoxin is specific for human Fc gamma RI/CD64, and specifically an epitope outside the Fc binding domain. The binding activity of the VH/VL antibody format was unaffected by fusion of the m22(scFv) coding regions to the truncated ETA coding sequences
Store at 4°C in the dark.
IgG1 κ
Flow Cytometry
H22
Flow Cytometry
CD64 antigen, Fc fragment of IgG, high affinity Ia, receptor (CD64), FCG1, Fc-gamma receptor I B2, Fc-gamma RI, Fc-gamma RIA, FcgammaRIa, FCGR1, FcRI, FLJ18345, high affinity Ia, receptor for (CD64), high affinity immunoglobulin gamma Fc receptor I, IgG Fc receptor I
Human
Protein A purified
RUO
2209
Human
Purified
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.